Physician profile
Jigar Patel
NPI 1235394412
$2,890.03
in general payments reported to CMS, 2019-2025
21 companies · $898 in 2025
The $898 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $54.15 · 2021: $207 · 2022: $316 · 2023: $585 · 2024: $706 · 2025: $898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,188.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $540.03 | 2021-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $479.24 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $444.76 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Exact Sciences Corporation | $305.20 | 2023-2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $161.83 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $158.72 | 2025 | Zoryve |
| Abbott Laboratories | $144.81 | 2023-2025 | Freestyle Libre 3, Jot Dx |
| Pfizer INC. | $139.03 | 2021-2025 | |
| Abbvie INC. | $113.00 | 2022 | |
| Phathom Pharmaceuticals, INC. | $83.41 | 2024-2025 | Voquezna |
| Amgen INC. | $62.63 | 2023-2025 | Otezla, Repatha, Otezla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.37 | 2022-2025 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.69 | 2023-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $29.44 | 2022 | |
| Sumitomo Pharma America, INC. | $23.57 | 2024 | Gemtesa |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $23.23 | 2022 | |
| Ironwood Pharmaceuticals, INC | $21.63 | 2024 | |
| Renalytix Ai, INC. | $19.36 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Allergan, INC. | $17.31 | 2020 | |
| Sanofi Pasteur INC. | $16.99 | 2023 | |
| Paratek Pharmaceuticals, INC. | $14.78 | 2023 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jigar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.